Therefore, these findings lead to a speculation that all the processes including the occurrence of transient cerebral ischemia or Aβ excess, amplification of oxidative stress, and MCP-1/IL-1β-mediated inflammation might create a vicious cycle in mediating cognitive decline. The gene discussed is CCL2; the disease is transient ischemic attack.